Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
Abstract Treatments for alopecia areata (AA) have traditionally been prescribed off-label, and there has been no universal agreement on how to best manage the condition. Baricitinib is the first oral selective Janus kinase (JAK) inhibitor approved for the treatment of adults with severe AA. As a bet...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Adis, Springer Healthcare
2023-10-01
|
| Collection: | Dermatology and Therapy |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1007/s13555-023-01044-5 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|